the homogenized solution at 700 g. for 10 min, the sediment was used as the nuclei fraction. The supernatant was then centrifuged at 8000 g. for 10 min, the sediment was used as the mitochondria fraction. The resulting supernatant was separated by centrifuga.-tion at 105000 g. for 60 min; the sediment was used as the microsome fraction, and the supernatant was used as the supernatant fraction. Cadmium in each fraction was determined by atomic absorption spectrometry after wet-ashing of samples with nitric acid and hydrogen peroxide. The metallothionein content of the supernatant fraction of the liver was assayed by the gel filtration method described previously.8)
RESULTS
I. Cadmium distribution in the liver Table 1 shows the ratio of cadmium content in the fractions of nuclei, mitochondria, microsome, and supernatant to cadmium in the homogenate of the liver of mice treated with and without phenobarbital. As shown in Table  1 , the cadmium content in the liver of mice treated with phenobarbital was significantly higher compared with that of mice not treated with phenobarbital.
In comparison to the ratio of the cadmium content in each fraction to that in liver homogenate in the control group, the group treated with phenobarbital had significantly higher cadmium content in the supernatant fraction and significantly lower cadmium content in the nuclei fraction at both 4 and 24 hr after cadmium injection, but no differences were noted in the mitochondria and microsome fraction.
From these results, it can be seen that the increase of cadmium content in the liver of mice treated with phenobarbital occurred in the supernatant fraction of liver.
II. Relationship of phenobarbital treatment and metallothionein induction in the liver Fig. 1 shows the cadmium distribution, as determined by the gel filtration method, in the supernatant fraction of the liver at 4 and 24 hr after cadmium injection in mice treated with and without phenobarbital. The peak at fraction number 47 is the metallothionein fraction. At 4 hr after cadmium injection, though most of the cadmium existed in combination with high molecular weight protein, a little of the cadmium was combined These results indicate that phenobarbital has some ability to induce metallothionein.
But it is difficult entirely to explain the remarkable increase of cadmium in the liver of mice treated with phenobarbital from this result because the induction of metallothionein is very low with phenobarbital treatment compared with the case of pretreatment with a small dose of cadmium.8) Metallothionein increased repidly in the supernatant fraction of the liver after cadmium injection, reaching a maximal level on the 8th day after cadmium injection, 10) and this maximal concentration of metallothionein was maintained for long time in the liver. However, the duration of tolerance after the pretreatment with cadmium lasted only for 3 days.4) From these results, it will be difficult to explain the mechanism of this tolerance only from the induction of metallothionein. Since phenobarbital has been reported to accelerate cadmium in the liver,7) we examined the cadmium distribution in the liver after post-phenobarbital treatment cadmium injection, and observed that in the homogenized liver of mice treated with phenobarbital, the cadmium content was higher in the supernatant fraction and lower in the nuclei fraction than that of control mice. Since metallothionein was found in the supernatant fraction of liver, it was investigated whether phenobarbital treatment may have induced the metallothionein. The amount of cadmium bound to metallothionein in the liver was slightly higher in mice treated with phenobarbital but not as much as observed in rats pretreated with a small dose of cadmium.8) The results of the present experiment suggest that a mechanism other than the induction of metallothionein will account for the protective effect of phenobarbital on cadmium toxicity, but this protective effect is still unknown.
